Glomerular albumin permeability as an in vitro model for characterizing the mechanism of focal glomerulosclerosis and predicting post-transplant recurrence

被引:13
|
作者
Ghiggeri, GM [1 ]
Artero, M
Carraro, M
Candiano, G
Musante, L
Bruschi, M
Zennaro, C
Ginevri, F
Caridi, G
Faccini, L
Perfumo, F
Gusmano, R
机构
[1] G Gaslini Childrens Hosp, Lab Nephrol, I-16148 Genoa, Italy
[2] G Gaslini Childrens Hosp, Lab Pathophysiol Uremia, I-16148 Genoa, Italy
[3] Univ Trieste, Inst Internal Med, Trieste, Italy
[4] KIDney FUND, Genoa, Italy
关键词
focal segmental glomerulosclerosis; nephrotic syndrome; proteinura; post-transplant recurrence;
D O I
10.1111/j.1399-3046.2004.00178.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The putative mechanisms of proteinuria in idiopathic focal glomerulosclerosis and of its post-transplant recurrence are discussed. It is proposed that a balance between circulating factors with permeability activity on glomeruli and putative inhibitors play a key role. The characterization of inductors is currently in progress; most inhibitors appear to be apolipoproteins (mainly apoJ and apo E) but we cannot exclude other substances. The goal is now to evaluate the concentration of both inducers and inhibitors of glomerular permeability in vivo. Permeability activity in plasma of patients with FSGS with and without recurrence of the disease may be evaluated by an in vitro functional essay with isolated glomeruli. Published data on permeability activity evaluated with this method in different proteinuric states gave, however, controversial results and this test cannot be readily considered of clear clinical utility. Only the definitive characterization and quantification in vivo of the different molecules that play a role in FSGS may furnish adequate answer.
引用
收藏
页码:339 / 343
页数:5
相关论文
共 50 条
  • [21] Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis
    Savin, VJ
    Sharma, R
    Sharma, M
    McCarthy, ET
    Swan, SK
    Ellis, E
    Lovell, H
    Warady, B
    Gunwar, S
    Chonko, AM
    Artero, M
    Vincenti, F
    Fine, R
    Wood, E
    Trachtman, H
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (14): : 878 - 883
  • [22] Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier
    Li, Min
    Alfieri, Carlo Maria
    Morello, William
    Cellesi, Francesco
    Armelloni, Silvia
    Mattinzoli, Deborah
    Montini, Giovanni
    Messa, Piergiorgio
    JOURNAL OF NEPHROLOGY, 2020, 33 (04) : 747 - 755
  • [23] Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier
    Min Li
    Carlo Maria Alfieri
    William Morello
    Francesco Cellesi
    Silvia Armelloni
    Deborah Mattinzoli
    Giovanni Montini
    Piergiorgio Messa
    Journal of Nephrology, 2020, 33 : 747 - 755
  • [24] Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence
    Mujtaba, Muhammad A.
    Sharfuddin, Asif A.
    Book, Benita L.
    Goggins, William C.
    Khalil, Ali A.
    Mishler, Dennis P.
    Fridell, Johnathan A.
    Yaqub, Muhammad S.
    Taber, Tim E.
    CLINICAL TRANSPLANTATION, 2015, 29 (07) : 606 - 611
  • [25] The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis
    Carraro, M
    Zennaro, C
    Artero, M
    Candiano, G
    Ghiggeri, GM
    Musante, L
    Sirch, C
    Bruschi, M
    Faccini, L
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (08) : 1969 - 1975
  • [26] Anti-nephrin autoantibodies: novel predictors of post-transplant recurrence of focal segmental glomerular sclerosis
    Hattori, Motoshi
    KIDNEY INTERNATIONAL, 2024, 106 (04) : 570 - 572
  • [27] ORAL GALACTOSE THERAPY FOR THE TREATMENT OF RECURRENT POST-TRANSPLANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS
    Robson, K.
    Langsford, D.
    Dwyer, K.
    Goodman, D.
    Langham, R.
    NEPHROLOGY, 2014, 19 : 87 - 87
  • [28] Treatment of Post-Transplant Recurrent Focal Segmental Glomerulosclerosis With a Monoclonal Antibody Rituximab
    Pathak, V.
    Madhavan, D.
    Balasundaram, S.
    Kumar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 534 - 534
  • [29] Late post-transplant focal segmental glomerulosclerosis after covid-19: causal factor or recurrence of primary disease?
    Osuna Soto, J.
    Leiva-Cepas, F.
    Sanchez Ramirez, I.
    Galvez Medina, M. J.
    Ortega Salas, R.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S312 - S312
  • [30] FSGS POST-TRANSPLANT RECURRENCE: IDENTIFICATION OF A PUTATIVE PERMEABILITY FACTOR
    Ollero, Mario
    Henique, Carole
    Chhuon, Cerina
    Sendeyo, Kelhia
    Zhang, Shao-Yu
    Guerrera, Ida Chiara
    Sahali, Djillali
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 82 - 82